Bradford-Based Addiction Clinic Steps Up Outpatient Services to Support Individuals During COVID-19
A Bradford-based addiction clinic has expanded its outpatient services in response to heightened demand due to COVID-19.
The pressures of lockdown have triggered a crisis for many people with opiate and alcohol addictions and their families. Existing addiction problems have escalated due to the stress and isolation associated with the pandemic, while spending time in close proximity to family members under lockdown means loved ones have a higher chance of identifying the problem.
A significant proportion of people with addiction have been reluctant to seek treatment in hospital, therefore the BONDS™ Clinic is expanding its outpatient service which offers people a way to free themselves from their addiction in their own home – reducing the need to travel during the pandemic. The treatment is complemented by support from an experienced clinical team who are available on the phone and via video consultation, ensuring the individual feels supported every step of the way.
The BONDS™ Clinic outpatient service uses the BONDS™ (Beaini Opiate Naltrexone Detoxification System) treatment protocol, an abstinence-based treatment programmes that frees people from addiction and helps to integrate them into society as part of their recovery. The treatment uses dual diagnosis to holistically address both the substance addiction and any underlying mental health issues in a planned and cohesive way.
“Accessible, proven treatment”
Dr Amal Beaini, Medical Director at the BONDS™ Clinic, comments: “We recognise that COVID-19 has led many individuals with addiction, alongside their loved ones, to feel at breaking point with nowhere to turn. At a time when it is more challenging to be treated as an inpatient, through our expanded outpatient service, we aim to provide an accessible, proven treatment which provides reassurance and helps individuals get their lives back.
Our outpatient service offers individuals a greater degree of freedom and flexibility and allows them to immediately apply what they have learned and practiced in treatment to their everyday life. The enormity of the problem is unparalleled and we want to be able to help as many individuals as possible by opening our doors to the immediate catchment area and beyond.”
The BONDS™ (Beaini Opiate Naltrexone Detoxification System) protocol was established in 2000 by Dr Amal Beaini, a Specialised Consultant Psychiatrist with over 25 years’ experience in addiction.
There are 4 steps:
• An assessment with the BONDS™ clinic team to determine diagnosis and develop a personalised 12-month plan. This assessment will focus on a person’s situation as a whole to determine the psychological, biological and social factors that could be contributing to the addiction
• Typically, a 5- to 7-day detox procedure, using wakeful sedation over 3 days, to clear the addictive substance from the body while controlling any withdrawal symptoms
• Prescription of a non-addictive, opiate-blocking drug, as a tablet or implant to support abstinence
• A treatment and abstinence support plan, based on individual clinical needs and preferences, that includes mental health therapies combined with 12-month maintenance treatment with an opiate-blocking drug in order to deal with the psychiatric disorder and the addiction simultaneously.
For more information visit: www.thebondsclinic.com.